Innovative Ultrasound Technology in Neuromuscular Disease
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology, Neurology, Neurology, Neurology, Neurology, Neurology, Neurology, Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 21 - 80 |
| Updated: | 9/9/2018 |
| Start Date: | December 2013 |
| End Date: | December 2021 |
| Contact: | Hilda Gutierrez, MD |
| Email: | hgutier1@bidmc.harvard.edu |
| Phone: | 617-667-3053 |
This study is utilizing ultrasound measurement to measure neuromuscular disease status in
adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that
ultrasound can be utilized as a tool to determine if a disease is responding to therapy or
progressing.
adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that
ultrasound can be utilized as a tool to determine if a disease is responding to therapy or
progressing.
Inclusion Criteria:
- History of a well-defined, localized or generalized neuromuscular condition producing
weakness or muscle atrophy, including disuse atrophy.
Exclusion Criteria:
- Multiple generalized neuromuscular conditions.
We found this trial at
1
site
330 Brookline Ave
Boston, Massachusetts 02215
Boston, Massachusetts 02215
617-667-7000
Principal Investigator: Seward B Rutkove, MD
Phone: 617-667-3015
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
Click here to add this to my saved trials
